GS-EU-276-4027: A Cross Sectional Post Authorization Safety Study to Assess Healthcare Provider’s Level of Awareness of Risk Minimisation Materials for Truvada® for Pre Exposure Prophylaxis in the European Union

13/06/2017
16/02/2024
EU PAS number:
EUPAS19479
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

This study consists of a cross sectional survey, which will be conducted in France, Germany, Ireland, Netherlands, Norway, Spain, and the United Kingdom in order to assess prescriber awareness of the Risk Minimisation Materials (RMMs).
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No